Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 4 (2007), Issue 1 (January)

1. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?
   J Med Genet, 44(1): e63. [Abstract] [Full-text]
2. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
   J Med Genet, 44(1): 44-50. [Abstract] [Full-text]
3. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.
   Proc Natl Acad Sci U S A, 104(2): 403-9. [Abstract] [Full-text]
4. Three methods of assessing values for advance care planning: comparing persons with and without dementia.
   J Aging Health, 19(1): 123-51. [Abstract] [Full-text]
5. Family caregiving to those with dementia in rural Alabama: racial similarities and differences.
   J Aging Health, 19(1): 3-21. [Abstract] [Full-text]
6. Mother-adult daughter relationships within dementia care: a critical analysis.
   J Fam Nurs, 13(1): 13-32. [Abstract] [Full-text]
7. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
   Brain Res, 1131(1): 187-96. [Abstract] [Full-text]
8. Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: Method and validation on controls and patients with Alzheimer's disease.
   Neuroimage, 34(3): 996-1019. [Abstract] [Full-text]
9. Multivariate network analysis of fiber tract integrity in Alzheimer's disease.
   Neuroimage, 34(3): 985-95. [Abstract] [Full-text]
10. Disgust and Huntington's disease.
    Neuropsychologia, 45(6): 1135-51. [Abstract] [Full-text]
11. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.
    Neurology, 68(3): 223-8. [Abstract] [Full-text]
12. Functional connectivity of the prefrontal cortex in Huntington's disease.
    J Neurol Neurosurg Psychiatry, 78(2): 127-33. [Abstract] [Full-text]
13. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting.
    J Neurol Neurosurg Psychiatry, 78(2): 157-61. [Abstract] [Full-text]
14. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 78(2): 123-6. [Abstract] [Full-text]
15. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Neuroscientist, 13(1): 38-48. [Abstract] [Full-text]
16. Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL.
    Brain, 130: 357-67. [Abstract] [Full-text]
17. Huntington's disease.
    Lancet, 369(9557): 218-28. [Abstract] [Full-text]
18. The efficacy of acupressure for decreasing agitated behaviour in dementia: a pilot study.
    J Clin Nurs, 16(2): 308-15. [Abstract] [Full-text]
19. Reliability and validity of the Japanese version of the Frontal Assessment Battery in patients with the frontal variant of frontotemporal dementia.
    Psychiatry Clin Neurosci, 61(1): 78-83. [Abstract] [Full-text]
20. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Neuropathol Appl Neurobiol, 33(1): 43-55. [Abstract] [Full-text]
21. The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse.
    J Pharmacol Exp Ther, 320(2): 552-8. [Abstract] [Full-text]
22. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
    Neurology, 68(4): 288-91. [Abstract] [Full-text]
23. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.
    Nat Rev Mol Cell Biol, 8(2): 101-12. [Abstract] [Full-text]
24. Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis.
    J Neurosci, 27(4): 893-900. [Abstract] [Full-text]
25. The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes.
    J Neurosci, 27(4): 868-80. [Abstract] [Full-text]
26. Disturbed cross talk between insulin-like growth factor I and AMP-activated protein kinase as a possible cause of vascular dysfunction in the amyloid precursor protein/presenilin 2 mouse model of Alzheimer's disease.
    J Neurosci, 27(4): 824-31. [Abstract] [Full-text]
27. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.
    J Neurosci, 27(4): 796-807. [Abstract] [Full-text]
28. Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice.
    J Neurosci, 27(4): 751-61. [Abstract] [Full-text]
29. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.
    Eur J Neurol, 14(2): 168-73. [Abstract] [Full-text]
30. Relevance of 10-min delayed recall in dementia screening.
    Eur J Neurol, 14(2): 144-9. [Abstract] [Full-text]
31. CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies.
    Eur J Neurol, 14(2): 121-4. [Abstract] [Full-text]
32. Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus).
    J Gen Virol, 88: 688-95. [Abstract] [Full-text]
33. Memantine in the treatment of mild-to-moderate Alzheimer's disease.
    Expert Opin Pharmacother, 8(2): 203-14. [Abstract] [Full-text]
34. A systematic review of the treatment studies in Huntington's disease since 1990.
    Expert Opin Pharmacother, 8(2): 141-53. [Abstract] [Full-text]
35. Patterns of neuropsychological impairment in frontotemporal dementia.
    Neurology, 68(5): 369-75. [Abstract] [Full-text]
36. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.
    Neurology, 68(5): 350-5. [Abstract] [Full-text]
37. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.
    FEBS Lett, 581(3): 475-8. [Abstract] [Full-text]
38. Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease.
    Proc Natl Acad Sci U S A, 104(5): 1691-6. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.